[Immunological safety and sensitizing effect of an MB-7-based vaccine against hepatitis A].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 15529858)

Published in Vopr Virusol on November 08, 2004

Authors

M A Smerdova, S V Usova, M P Smolina, S V Netesov, A G Maĭdaniuk, M A Muntianova, Iu V Nemtsov, N I Kriuk, V V Iashin, L G Karpovich, T V Kalashnikova

Articles by these authors

GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology (1995) 5.34

The envelope glycoprotein of Ebola virus contains an immunosuppressive-like domain similar to oncogenic retroviruses. FEBS Lett (1992) 2.24

Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infections. J Infect Dis (1999) 1.83

A comparison of the nucleotide sequences of eastern and western equine encephalomyelitis viruses with those of other alphaviruses and related RNA viruses. Virology (1993) 1.67

Characterization of the L gene and 5' trailer region of Ebola virus. J Gen Virol (1999) 1.63

The complete nucleotide sequence of the Popp (1967) strain of Marburg virus: a comparison with the Musoke (1980) strain. Arch Virol (1995) 1.33

Animal pathology of filoviral infections. Curr Top Microbiol Immunol (1999) 1.22

[Complete nucleotide sequence of the Eastern equine encephalomyelitis virus genome]. Mol Gen Mikrobiol Virusol (1991) 1.01

[Attempts to develop a vaccine against Ebola fever]. Vopr Virusol (1996) 1.00

The VP35 and VP40 proteins of filoviruses. Homology between Marburg and Ebola viruses. FEBS Lett (1993) 0.94

The GP-protein of Marburg virus contains the region similar to the 'immunosuppressive domain' of oncogenic retrovirus P15E proteins. FEBS Lett (1993) 0.92

[Primary structure of the full-size DNA copy of the influenza virus A/Kiev/59/79 (H1N1) PB1 gene protein]. Bioorg Khim (1987) 0.90

Genetic diversity of hantaviruses associated with hemorrhagic fever with renal syndrome in the far east of Russia. Virus Res (2000) 0.90

Complete nucleotide sequences of Marburg virus genes 5 and 6 encoding VP30 and VP24 proteins. Biochem Mol Biol Int (1995) 0.88

[The ultrastructural changes in guinea pig organs during the serial passage of the Ebola virus]. Vopr Virusol (1993) 0.86

[Genetic identification of the Crimean-Congo hemorrhagic fever virus during epidemic outbreak in Kazakhstan in 2000]. Mol Gen Mikrobiol Virusol (2002) 0.82

Molecular epidemiology of the hepatitis C virus in Western Siberia. J Med Virol (2005) 0.82

Highly pathogenic influenza virus H5N1 found in western Siberia is genetically related to viruses that circulated in Southeast Asia in 2003-2005. Dokl Biol Sci (2006) 0.82

[Characteristics of Crimean-Congo hemorrhagic fever virus circulating in Russia and Central Asia]. Vopr Virusol (2002) 0.82

[Comparative study of the reactivity, safety and immunogenicity of "Havrix" inactivated hepatitis A vaccine]. Vopr Virusol (2001) 0.81

Localization of four antigenic sites involved in Venezuelan equine encephalomyelitis virus protection. Arch Virol (1994) 0.81

[The 2003 results of monitoring of influenza A virus in the populations of wild birds in the south of Western Siberia]. Vopr Virusol (2006) 0.81

[Comparison of the amino acid sequence of structural proteins from attenuated and pathogenic strains of the Venezuelan equine encephalomyelitis virus]. Dokl Akad Nauk SSSR (1991) 0.81

[Genetic diversity of group A rotavirus isolates found in Western Siberia in 2007-2011]. Mol Gen Mikrobiol Virusol (2012) 0.80

[A new genetic variant of the PUUV virus from the Maritime Territory and its natural carrier red-grey vole Clethrionomys rufocanus]. Vopr Virusol (2004) 0.80

[The immunogenic properties of a recombinant vaccinia virus with an incorporated DNA copy of the 26S RNA of the Venezuelan equine encephalomyelitis virus]. Vopr Virusol (1994) 0.79

[Apoptin enhances the oncolytic activity of vaccinia virus]. Mol Biol (Mosk) (2014) 0.79

Human recombinant laminin-binding protein: isolation, purification, and crystallization. Biochemistry (Mosc) (2000) 0.78

Genetic analysis of the M RNA segment of Crimean-Congo hemorrhagic fever virus strains involved in the recent outbreaks in Russia. Arch Virol (2004) 0.78

[Oncolytic poxviruses]. Mol Gen Mikrobiol Virusol (2012) 0.78

[Oncolytic enteroviruses]. Mol Biol (Mosk) (2012) 0.78

Blastogenic lymphocyte response as indicator of cell-mediated immunity in humans vaccinated with live and inactivated influenza vaccines. Acta Virol (1983) 0.77

[Surveillance for avian influenza virus in synanthropic birds during epizootic and postepizootic periods on the south of west Siberia]. Zh Mikrobiol Epidemiol Immunobiol (2007) 0.77

[Molecular genetic characteristics of astroviruses circulating in Novosibirsk]. Vopr Virusol (2011) 0.77

[Comparative study of the morphology and antigenic properties of recombinant analogs of a Marburg virus nucleoprotein]. Mol Biol (Mosk) (2001) 0.77

[Effect of mutations in genes of Venezuelan equine encephalomyelitis virus structural proteins on its attenuation]. Dokl Akad Nauk (1992) 0.77

[ELISA and RT-PCR-based research of viruses in the ticks collected in the foci of Crimean-Congo fever in Kazakhstan and Tajikistan in 2001-2002]. Vopr Virusol (2005) 0.77

[Genetic characteristics of the S-segment of RNA from two strains of the Crimean-Congo hemorrhagic fever virus isolated in the south of Russia and in Uzbekistan]. Vopr Virusol (2003) 0.77

[Recombinant equine Venezuelan encephalomyelitis virus, expressing HBsAg]. Dokl Akad Nauk (1993) 0.77

[Hepatitis B markers in southern Altaĭ inhabitants of the village of Mendur-Sokkon (the Republic of Altaĭ). HBsAg subtyping in hepatitis B virus isolates with monoclonal antibodies]. Zh Mikrobiol Epidemiol Immunobiol (2001) 0.76

[Oncolytic adenoviruses in anti-cancer therapy: current status and perspectives]. Mol Biol (Mosk) (2012) 0.76

[Nucleotide sequence of genes and complete amino acid sequence of tick-borne encephalitis virus strain 205]. Mol Gen Mikrobiol Virusol (1991) 0.76

[Primary structure of proteins of the nsP2 and nsP3 polymerase complex confirm the recombinant nature of western encephalitis virus]. Dokl Akad Nauk (1994) 0.76

[Oncolytic parvoviruses. A new approaches for cancer therapy]. Vestn Ross Akad Med Nauk (2012) 0.76

[Immunogenicity of a recombinant strain of vaccinia virus, expressing a Venezuelan equine encephalomyelitis virus structural protein gene in peroral immunization]. Vopr Virusol (2001) 0.76

[Study of virus contamination of Ixodes ticks in the foci of Crimean-Congo hemorrhagic fever in Kazakhstan and Tajikistan]. Zh Mikrobiol Epidemiol Immunobiol (2005) 0.76

[Immunobiological properties of vp24 protein of Ebola virus expressed by recombinant vaccinia virus]. Vopr Virusol (1997) 0.76

[Highly pathogenic avian influenza: a new pandemic threat and possibilities to resist it]. Vestn Ross Akad Med Nauk (2006) 0.76

[The occurrence rate of HGV/GBV-C RNA and risk factors in patients of narcological dispensary in Novosibirsk]. Zh Mikrobiol Epidemiol Immunobiol (2005) 0.76

A comparison of the nucleotide sequences of eastern and western equine encephalomyelitis viruses with those of other alphaviruses and related RNA viruses. Virology (1994) 0.76

[Frequency of encountering markers of viral hepatitis A, B, and C in the aboriginal inhabitants of the northwest region of Siberia]. Vopr Virusol (1995) 0.76

[Occurrence of markers, distribution of genotypes and risk factors for viral hepatitis C among some groups of the population in the Novosibirsk region]. Zh Mikrobiol Epidemiol Immunobiol (2004) 0.76

A chemical method to enrich RNA by molecules having 5'-terminal triphosphate groups. Nucleic Acids Res (1981) 0.75

[Oncolytic properties of some orthopoxviruses, adenoviruses and parvoviruses in human glioma cells]. Vestn Ross Akad Med Nauk (2013) 0.75

[Evaluation of the effectiveness of substance for diagnosing rotaviral infection under field conditions]. Vopr Virusol (1999) 0.75

Changes in the ultrastructure of chick embryo cells induced by infection with tick-borne encephalitis virus. Acta Virol (1966) 0.75

[Immunological aspects in studying attenuated strains of the tick-borne encephalitis virus complex]. Vestn Akad Med Nauk SSSR (1977) 0.75

Analysis of the hemagglutination activity domains of the Venezuelan equine encephalomyelitis and eastern equine encephalomyelitis viruses. Intervirology (1994) 0.75

[Indicators of erythrocytic hemostasis in patients with rheumatism of minimal degree of activity]. Vrach Delo (1985) 0.75

[Evaluation of reactivity and immunogenicity of a cultured concentrated inactivated vaccine against hepatitis A "Hep-A-In-Vak"]. Vopr Virusol (1996) 0.75

[The principles for standardizing serum panels intended for the quality assessment of diagnostic test systems (exemplified by an immunoenzyme test system for detecting HIV antibodies)]. Vopr Virusol (1992) 0.75

[The pathogenesis of infections in mice caused by virulent and attenuated variants of tick-borne encephalitis and Langat viruses]. Vopr Virusol (1971) 0.75

[Hep-A-in-Vac, a Russian cultured concentrated inactivated vaccine against hepatitis A]. Zh Mikrobiol Epidemiol Immunobiol (1998) 0.75

[A study of the thermoresistance of tick-borne encephalitis complex viruses possessing varying degrees of neurovirulence for laboratory animals]. Vopr Virusol (1969) 0.75

[Safety research of a vaccine preparation in hepatitis A derived from the MB-7 rapidly growing strain]. Vopr Virusol (2004) 0.75

[Blood volume determination in heart surgery patients using 51Cr-labeled erythrocytes]. Med Radiol (Mosk) (1982) 0.75

[The results of a controlled field trial of a dried erythrocytic immunoglobulin diagnostic agent for detecting the hepatitis A virus antigen]. Zh Mikrobiol Epidemiol Immunobiol (1991) 0.75

[Comparative study of the immunogenicity of the inactivated hepatitis A vaccine Hep-A-in-vac from experimental and clinical data]. Vopr Virusol (1996) 0.75

[Indices of lymphocyte functional activity in patients with recurrent cutaneous-genital herpes during treatment with a herpes vaccine]. Vopr Virusol (1986) 0.75

Immune response to different tick-borne encephalitis vaccines as revealed by lymphocyte blast transformation and virus neutralization tests. Acta Virol (1984) 0.75

[Determination of the growth properties of virological nutrient media by the cellular incorporation of a labelled precursor of DNA synthesis]. Vopr Virusol (1984) 0.75

[The isolation and study of the characteristics of a cytopathic strain of the hepatitis A virus]. Vopr Virusol (1994) 0.75

[Development of sera reference panels for quality control of ELISA diagnostic kits in Russia]. Vestn Ross Akad Med Nauk (1998) 0.75

[Indices of the immune status of recurrent herpes patients being treated with a herpes polyvaccine]. Vopr Virusol (1987) 0.75

[The effect of plasmapheresis on the rheological properties of the blood in patients with thrombosis of the central retinal vein]. Lik Sprava (1999) 0.75

[Characteristics of reactogenic and immunogenic properties of the children's variant of the domestic vaccine, "Gep-A-in-Vak", against hepatitis A]. Vopr Virusol (1999) 0.75

[Obtaining infectious Venezuelan equine encephalomyelitis virus based on a full length DNA copy of its genome]. Dokl Akad Nauk (1992) 0.75

[Optimization of preparation conditions of an inactivated hepatitis A vaccine and its characteristics]. Vopr Virusol (1996) 0.75

[Blast transformation reaction of the peripheral blood lymphocytes from persons inoculated with a tick-borne encephalitis vaccine]. Vopr Virusol (1982) 0.75

[Changes in the population composition of the peripheral blood lymphocytes and the humoral immune response of persons inoculated with live influenza vaccines]. Zh Mikrobiol Epidemiol Immunobiol (1984) 0.75

[Prevalence of serological markers for viral hepatitis B and C in patients and medical personnel in the hematologic ward of Novosibirsk city hospital No. 2]. Vopr Virusol (1997) 0.75

[Mechanisms for the therapeutic effect of herpes polyvaccines in chronic ophthalmic herpes and genital herpes]. Vopr Virusol (2000) 0.75

[Quantitative characteristics of the process of solubilizing hemagglutinin isolated from influenza viruses H1N1 and H3N2]. Vopr Virusol (1987) 0.75

[The use of the autocoagulation test for the detection of coagulopathies in rheumatoid arthritis]. Klin Lab Diagn (1995) 0.75

[Elaboration of live measles vaccine technology on human embryo lung diploid cell culture L-68]. Vestn Ross Akad Med Nauk (1998) 0.75

[Radioisotope studies in the practice of an intensive therapy department]. Kardiologiia (1978) 0.75

[Certain biological properties of mutant human tumor necrosis factor-alpha]. Biull Eksp Biol Med (1998) 0.75

[Comparative study of B-lymphocyte activity in the spleen of mice infected with viruses of the tick-borne encephalitis complex]. Vopr Virusol (1978) 0.75

[Lymphocyte-dependent antibodies in the blood serum after transplantation of cadaveric kidney]. Lab Delo (1978) 0.75

[Preparation and study of recombinant strains of Venezuelan equine encephalomyelitis virus expressing the PreS2-S gene of the hepatitis B virus]. Vopr Virusol (1996) 0.75

[Isolation and characteristics of anti-adenovirus monoclonal antibodies in immunoenzyme and immunofluorescent reactions]. Vopr Virusol (2001) 0.75

[Effect of donor immunization with different influenza vaccines on the insulin level of the blood serum]. Zh Mikrobiol Epidemiol Immunobiol (1984) 0.75

[Status of antiviral immunity in patients with recurrent herpes]. Vestn Dermatol Venerol (1987) 0.75

[Reproduction of various arboviruses at high temperature as a genetic marker]. Biull Eksp Biol Med (1967) 0.75

[Current complex diagnosis of diffuse alveococcosis of the liver]. Khirurgiia (Mosk) (1987) 0.75

[Features of immunogenesis in simians infected with attenuated strains of tick-borne encephalitis and Langat virus]. Vopr Virusol (1981) 0.75

[Radioimmunological study of the antigenic conformity of the hemagglutinins of vaccinal and epidemic strains of influenza virus]. Vopr Virusol (1985) 0.75

[Heterogeneity of monospecific antibodies to the hemagglutinin of influenza virus H3N2 studied by radioimmunological analysis]. Vopr Virusol (1985) 0.75